compound tirzepatide dosing chart Zepbound® Dosage Guide compounded tirzepatide calculator dosing chart

Median (Q1, Q3) LDL-C at baseline was 398 (343, 475) mg/dL, and all patients were on statins (atorvastatin or rosuvastatin) and ezetimibe

When should you contact a healthcare provider about side effects

Managing reflux and choosing lighter meals may also improve symptoms

Linear mixed models estimated changes over 618 months, stratified by engagement, metabolic status, and ethnicity

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

The company has disclosed three new biosimilar oncology assets, trastuzumab subcutaneous, nivolumab and pembrolizumab, targeting reference products Herceptin SC, Opdivo and Keytruda respectively, therapies that together generated over $40 billion in global sales in 2024